JPH01199913A - Liniment - Google Patents
LinimentInfo
- Publication number
- JPH01199913A JPH01199913A JP63024694A JP2469488A JPH01199913A JP H01199913 A JPH01199913 A JP H01199913A JP 63024694 A JP63024694 A JP 63024694A JP 2469488 A JP2469488 A JP 2469488A JP H01199913 A JPH01199913 A JP H01199913A
- Authority
- JP
- Japan
- Prior art keywords
- liniment
- pearl powder
- powder
- pearl
- heat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000865 liniment Substances 0.000 title abstract description 9
- 229940040145 liniment Drugs 0.000 title abstract description 8
- 239000000843 powder Substances 0.000 claims abstract description 22
- 239000011248 coating agent Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 abstract description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 5
- 239000011575 calcium Substances 0.000 abstract description 5
- 229910052791 calcium Inorganic materials 0.000 abstract description 5
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 abstract description 4
- 229910001424 calcium ion Inorganic materials 0.000 abstract description 4
- 208000014617 hemorrhoid Diseases 0.000 abstract description 4
- 239000004615 ingredient Substances 0.000 abstract description 3
- 206010028980 Neoplasm Diseases 0.000 abstract description 2
- 238000004061 bleaching Methods 0.000 abstract description 2
- 230000001954 sterilising effect Effects 0.000 abstract description 2
- 230000002459 sustained effect Effects 0.000 abstract description 2
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 abstract description 2
- 201000004647 tinea pedis Diseases 0.000 abstract description 2
- 238000002156 mixing Methods 0.000 abstract 2
- 241000213810 Ephelis Species 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 238000004659 sterilization and disinfection Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 230000000694 effects Effects 0.000 description 4
- 239000006071 cream Substances 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 244000132059 Carica parviflora Species 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 208000002260 Keloid Diseases 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001669 calcium Chemical class 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000005722 itchiness Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 210000001117 keloid Anatomy 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
〔従来の技術〕
従来から活性カルシウムイオンを含有する水は医薬ある
いけ保健薬的な作男、効果を有することが知られている
。このような活性カルシウム含有水ンを含有する水はカ
ルシウム含有水を電気分解することによって得られる。[Detailed Description of the Invention] [Industrial Field of Application] [Prior Art] It has been known that water containing active calcium ions has medicinal and health effects. Water containing such active calcium-containing water can be obtained by electrolyzing calcium-containing water.
しかしながら上記活性カルシウムイオンを含有する水は
長期にわたる持続的効果がなく、例えば化粧品や塗布薬
のような長期保存を必要とする製品には配合することが
出来ない。However, water containing active calcium ions does not have long-lasting effects and cannot be incorporated into products that require long-term storage, such as cosmetics and liniments.
本発明は上記従来の間穎点を解決する手段として、加熱
処理した真珠粉末を配合した塗布剤に関するものである
。The present invention relates to a coating agent containing heat-treated pearl powder as a means for solving the above-mentioned conventional glistening point problem.
本発明に用いられる真珠粉末は加熱処理される。The pearl powder used in the present invention is heat treated.
加熱処理は２００〜１６００℃の広範囲にわたる温度で
１〜５０時間程度行われるが、診処理温度によって該真
珠粉末の効果は若干相違し、該真珠粉末の効果が最とも
顕著になるのは７００〜９００℃程度の温度範囲の加熱
処理である。The heat treatment is carried out at a wide range of temperatures from 200 to 1600°C for about 1 to 50 hours, but the effect of the pearl powder differs slightly depending on the treatment temperature, and the effect of the pearl powder becomes most noticeable at temperatures between 700 and 1600°C. This is a heat treatment in a temperature range of about 900°C.
該真珠粉末には更に陶土、貝殻粉末、サンゴ粉末９旧灰
石粉末、セラミック粉末等の増量剤が混合されてもよい
。該増量剤は加熱処理の前後で混、合され得るが、望ま
しくは加熱処理前に混合される。The pearl powder may further be mixed with a filler such as china clay, shell powder, coral powder, graystone powder, and ceramic powder. The extender may be mixed before or after the heat treatment, but is preferably mixed before the heat treatment.
本発明の塗布剤は液状、ローシ■ン状、水中油または油
中水の何れか−のエマルジーン、水性ゲル組成物、泡状
、スプレー、あるいは座薬等の局部に塗布するに濾光な
形吠とされる。そして該真珠粉末は上記塗布剤に対して
望ましくは２０〜５０重量％、更に望ましくは３０〜°
４０重量％程度添加混合される。The liniment of the present invention may be in the form of a liquid, a lotion, an oil-in-water or water-in-oil emulsion, an aqueous gel composition, a foam, a spray, or a filtered form for topical application such as a suppository. It is said that The pearl powder is preferably 20 to 50% by weight, more preferably 30 to 50% by weight based on the coating agent.
About 40% by weight is added and mixed.
本発明の塗布剤には更に鎮痛剤、消炎剤、抗菌剤、界面
活性剤、湿潤剤、植物油、鉱物油、刺激剤、清涼剤、香
料１色素等の他の成分が添加されてもよい。本発明の真
珠粉末はこれら他の成分の効力を妨げず、またこれら他
の成分によって効力を妨げられない。Other components such as analgesics, anti-inflammatory agents, antibacterial agents, surfactants, humectants, vegetable oils, mineral oils, stimulants, cooling agents, fragrances and pigments may also be added to the coating composition of the present invention. The pearl powder of the present invention does not interfere with the efficacy of these other ingredients, nor is its efficacy inhibited by these other ingredients.
真珠粉を加熱すると該真珠粉末に含まれるコンキオリシ
蛋白質含有燐酸カルシウム中のカルシウムが活性化する
と思われる。このような活性化されたカルシウムを含有
する真珠粉末は塗布剤中で長期にわたり徐々に活性カル
シウムイオンを放出し、消炎、殺菌、漂白１組織回生、
血行促進等において持続的効果を示すものと思われる。It is believed that heating the pearl powder activates the calcium in the conchiolisiprotein-containing calcium phosphate contained in the pearl powder. Pearl powder containing such activated calcium gradually releases active calcium ions over a long period of time in a liniment, and has anti-inflammatory, sterilizing, bleaching, tissue regeneration,
It is thought to have a lasting effect in promoting blood circulation, etc.
したがって本発明の塗布剤は持続的な活性カルシウム効
果を示し保存性が極めて良い。Therefore, the liniment of the present invention exhibits a sustained active calcium effect and has an extremely good shelf life.
実施例１Ｃローレ・ン）
プロ？レングリコー／ｌ／ ２５ｇトリ
エタノールアミン １ｇ水
７ｇオレイン酸
１．５ｇポリエチレングリコール
七ソノステアレート １１ｇカー向μル
９３４（２重量％水溶液） ５０ｇ加熱処理
真珠粉末 ４０ｇ上記組成を混合して
ローションを調製する。該真珠粉末は７５０°Ｃ，６時
間の加熱処理を行ったものである。Example 1C Lauren Ng) Professional? Len glycol/l/ 25g triethanolamine 1g water
7g oleic acid
1.5g polyethylene glycol hepsonostearate 11g Curly μl 934 (2% by weight aqueous solution) 50g heat-treated pearl powder 40g The above composition is mixed to prepare a lotion. The pearl powder was heat treated at 750°C for 6 hours.
実施例２（クリーム）
白 油
４１ｇ微細晶ワックス ３ｇ液伏
ラノリン １０ｇソルビタンモノ
オシイΔ俊エステゾレ ５ｇ
ポリソルベート−８００，２５ｇ
水 ４１ｇ加
熱処理真珠粉末 ａｓｇ珠粉米粉末０
０’Ｃ，５時間の加熱処理を行ったものである。Example 2 (cream) White oil
41g Microcrystalline wax 3g Liquid lanolin 10g Sorbitan Monooshii ΔShun Estesole 5g
Polysorbate - 800.25g Water 41g Heat-treated pearl powder ASG pearl rice powder 0
Heat treatment was performed at 0'C for 5 hours.
実施例３（ローシーンの使用）
実施例１のローシ曹ンを２〜３度程度の火傷の患部に１
回塗布すれば水泡を生じた後のケロイドの生成が防止出
玉た。Example 3 (Use of Low Sheen) Apply 1 dose of Low Sheen from Example 1 to the affected area of 2nd to 3rd degree burns.
If you apply it twice, the formation of keloids after blisters will be prevented.
またシミソバカヌのある顔面に１日１回該ローシーンを
塗布したところ、１ケ月後には顕著な消失をみた。In addition, when I applied the Low Sheen once a day to my face where I had blemishes, I noticed that they had disappeared noticeably after one month.
更に凍傷の手に１日１回塗布したところ３週間で血行が
良好になりかゆみが止った。Furthermore, when applied once a day to frostbitten hands, blood circulation improved and the itching stopped within three weeks.
実施例４（クリームの使用）
実施例２のクリームを水虫患部に１日１回塗布したとこ
ろ２日後にはかゆみが止り、１週間後には治癒した。以
後時折塗布する事により根治した。Example 4 (Use of Cream) When the cream of Example 2 was applied to the affected area of athlete's foot once a day, the itching stopped after 2 days, and it was healed after 1 week. After that, it was cured by occasional application.
またニキビが多数発生した顔面に１日１回塗布したとこ
ろ２週間後にはニキビが消失した。When applied once a day to the face where many pimples had appeared, the pimples disappeared after two weeks.
更に外痔核を有する患部に１日朝晩２回塗布したところ
ｌＯ日日間ｔ・ゆみが止″！９．２週間で外痔核が根治
した。また化膿腫痔に数回塗布により急速な全治を見た
。Furthermore, when I applied it twice a day in the morning and evening to the affected area with external hemorrhoids, the itchiness stopped for days! The external hemorrhoids were cured completely in 9.2 weeks. Also, by applying it several times to pyogenic hemorrhoids, rapid complete healing was observed. Ta.
特許出願人 加 藤 正 俊
加藤 益浩
手続補正書
１．事件の表示 Ｄ−ｏ、ｚｔｌ１７ど／昭和６３年
２月４日提出の特許？ＩＢ
２、発明の名称
塗 布 剤
３、補正をする者
事件との関係 特許出願人
住 所 愛知県瀬戸市熊野町３８番地氏名 加藤 正
俊 （外１名）
４、代理人
〒４６７
住所 名古屋市瑞穂区弥富町月見ケ丘３２番地６、補
正により増加する発明の数
７、補正の対象
明細書「発明の詳細な説明」の欄
９、前記以外の補正をする者
事件との関係 特許出願人
住 所 愛知県瀬戸市水無瀬町１９番地氏名 加藤
益浩
８、補正の内容
１、第６頁第２行
「化膿種痘」を「化膿腫瘍」に補正する。Patent Applicant Tadashi Kato Masahiro Kato Procedural Amendment 1. Display of case D-o, ztl17/Patent filed on February 4, 1986? IB 2. Name application of the invention Agent 3. Relationship with the person making the amendment Patent applicant address 38 Kumano-cho, Seto City, Aichi Prefecture Name Masatoshi Kato (1 other person) 4. Agent address 467 Address Mizuho, Nagoya City 32-6 Tsukimigaoka, Yatomi-cho, Ward, Number of inventions increased by amendment 7, Column 9 of "Detailed explanation of the invention" in the specification subject to the amendment, Relationship with cases of persons making amendments other than the above Patent applicant address Aichi 19 Minase-cho, Seto City, Prefecture Name: Kato
Masuhiro 8, Contents of amendment 1, page 6, line 2, amend "suppurative smallpox" to "suppurative tumor."
Claims (1)
剤A coating agent characterized by containing heat-treated pearl powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63024694A JPH01199913A (en) | 1988-02-04 | 1988-02-04 | Liniment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63024694A JPH01199913A (en) | 1988-02-04 | 1988-02-04 | Liniment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH01199913A true JPH01199913A (en) | 1989-08-11 |
| JPH0581568B2 JPH0581568B2 (en) | 1993-11-15 |
Family
ID=12145276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP63024694A Granted JPH01199913A (en) | 1988-02-04 | 1988-02-04 | Liniment |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH01199913A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102716402A (en) * | 2012-07-18 | 2012-10-10 | 吴顺议 | External traditional Chinese medicine preparation for treating wound infection and preparation method thereof |
| WO2014077088A1 (en) * | 2012-11-13 | 2014-05-22 | 株式会社エヌエクス | Method for producing fired product of freshwater clam shell, and composition for ameliorating hepatic dysfunction which contains said fired product as active ingredient |
| CN110302342A (en) * | 2019-08-15 | 2019-10-08 | 刘振武 | A kind of paste and preparation method thereof for treating hemorrhoid |
-
1988
- 1988-02-04 JP JP63024694A patent/JPH01199913A/en active Granted
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102716402A (en) * | 2012-07-18 | 2012-10-10 | 吴顺议 | External traditional Chinese medicine preparation for treating wound infection and preparation method thereof |
| WO2014077088A1 (en) * | 2012-11-13 | 2014-05-22 | 株式会社エヌエクス | Method for producing fired product of freshwater clam shell, and composition for ameliorating hepatic dysfunction which contains said fired product as active ingredient |
| JP2014097917A (en) * | 2012-11-13 | 2014-05-29 | Nx Inc | Method of producing corbicula shell calcined product, and liver function disorder improving composition including the same as active ingredient |
| CN110302342A (en) * | 2019-08-15 | 2019-10-08 | 刘振武 | A kind of paste and preparation method thereof for treating hemorrhoid |
| CN110302342B (en) * | 2019-08-15 | 2021-06-01 | 刘振武 | Ointment for treating hemorrhoids and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0581568B2 (en) | 1993-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4124720A (en) | Therapeutic hydrodispersible emulsion | |
| WO2012033422A1 (en) | Medical cosmetic herbal composition on the basis of herbal mixture and the procedure for its obtention | |
| CN104013547B (en) | A kind of hemostasis brilliant white fresh breath type toothpaste and preparation method thereof | |
| US6344188B1 (en) | Wrinkle reducing cream | |
| JP3995720B2 (en) | Cosmetic body care preparation and process for its production | |
| JPH01199913A (en) | Liniment | |
| KR20160041302A (en) | Manufacturing method of cosmetic for acned skin containing hydrozol | |
| WO2014199156A1 (en) | Novel bath salt composition | |
| ES2409353T3 (en) | Dermatological composition for the treatment of bedsores | |
| KR20190101247A (en) | Method of manufacturing bath bomb composition and aromatic using green tea | |
| JPH02124834A (en) | Composition of treatment for injury and disease of tissue, and its deformation because of ture fungi, micro-organism and the like | |
| US3825563A (en) | Production of stable,nonhydrous,homogeneous,in natural and mineral oils soluble vitamin-e-active cream-base-co-esters of the mineral-oil-insoluble d-alpha-tocopheryl-acid-succinate with anhydrous oils | |
| JP3503880B2 (en) | Oral composition | |
| ES2682844B1 (en) | A composition for topical application comprising natural waxes and their uses | |
| JPH03157311A (en) | Cosmetic for common acne | |
| US20140127315A1 (en) | Caudal Salve | |
| JP2814229B2 (en) | Cosmetic composition | |
| RU2326651C1 (en) | Treatment and cosmetic cream for feet care | |
| RU2705162C1 (en) | Ointment for treating psoriasis (versions) | |
| RU2211025C1 (en) | Cosmetic agent with heating effect (massage cream, balsam "aidas" b) | |
| JPS6322506A (en) | External preparation for skin | |
| RU2157176C1 (en) | Curative balsam | |
| RU2157175C1 (en) | Natural cream | |
| RU2248198C2 (en) | Anti-burn preparation | |
| US8486424B1 (en) | Method of preparing a skin treatment composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |